Ophthalmology · Belleville, NJ
NPI
1043258353
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
1 Clara Maass Dr
Belleville, NJ, 07109
Phone (973) 844-1340
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
1,493 services
Medicare patients, 2024
260
Average age 77
Drug cost, 2024
$526K
1,589 prescriptions
Company payments, 2025
$691
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Lister was code 92012 (ophthalmological e&m), 864 times for 196 patients. In total Mark A Lister billed 1,493 services in 51 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 864 | 196 | $73.54 | $64K |
| 68761 Eye | Office | 98 | 50 | $145.35 | $14K |
| 76514 Ultrasound - Nonspecific | Office | 78 | 61 | $9.60 | $749 |
| 92014 Ophthalmological E&M | Office | 71 | 61 | $98.94 | $7,024 |
| 92004 Ophthalmological E&M | Office | 51 | 51 | $125.58 | $6,405 |
| 92071 Ophthalmological E&M | Office | 46 | 17 | $31.14 | $1,432 |
| 67820 Eye | Office | 41 | 21 | $14.33 | $587 |
| 92025 Test - Miscellaneous | Office | 38 | 22 | $28.85 | $1,096 |
| 65222 Eye | Office | 24 | 18 | $53.64 | $1,287 |
By year: 2022 $132K for 1,281 services; 2023 $134K for 1,408 services; 2024 $150K for 1,493 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Lister prescribed most often to Medicare patients was Ciprofloxacin Hcl, with 179 prescriptions and refills. In total Mark A Lister wrote 1,589 Medicare prescriptions that cost $526K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciprofloxacin Hcl Generic | 179 | 195 | 73 | $2,113 |
| Difluprednate Generic | 161 | 213 | 55 | $19K |
| Zirgan Ganciclovir | 100 | 123 | 20 | $58K |
| Latanoprost Generic | 93 | 142 | 15 | $853 |
| Prednisolone Acetate Generic | 87 | 104 | 37 | $2,736 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 85 | 86 | 46 | $954 |
| Timolol Maleate Generic | 71 | 158 | 23 | $864 |
| Famciclovir Generic | 52 | 106 | 15 | $8,049 |
| Rhopressa Netarsudil Mesylate | 47 | 72 | 16 | $21K |
| Valacyclovir Valacyclovir Hcl | 45 | 80 | 16 | $2,687 |
| Brimonidine Tartrate Generic | 44 | 73 | 12 | $3,647 |
| Trifluridine Generic | 42 | 50 | 13 | $7,707 |
| Xiidra Lifitegrast | 41 | 87 | 12 | $58K |
| Simbrinza Brinzolamide/Brimonidine Tart | 40 | 74 | 14 | $11K |
| Tyrvaya Varenicline Tartrate | 39 | 58 | Under 11 | $35K |
Brand drugs: 763 claims; generic drugs: 826 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Lister $691 ($691 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bausch & Lomb Americas Inc. with $295.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 5 | $295 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $238 |
| Glaukos Corporation GKOS | 1 | $56.92 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $52.12 |
| Alcon Vision LLC ALC | 3 | $49.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.